Waddell & Reed Financial’s Acadia Pharmaceuticals ACAD Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-400,000	Closed	-$8.99M	–	540
2018 Q1	$8.99M	Sell	400,000 -2,481,692	-86%	-$68.7M	0.02%	435
2017 Q4	$86.8M	Sell	2,881,692 -184,572	-6%	-$5.9M	0.19%	132
2017 Q3	$116M	Sell	3,066,264 -77,147	-2%	-$2.51M	0.26%	106
2017 Q2	$87.7M	Buy	3,143,411 +51,434	+2%	+$1.53M	0.19%	142
2017 Q1	$106M	Buy	3,091,977 +1,912	+0.1%	+$67.5K	0.23%	120
2016 Q4	$89.1M	Buy	3,090,065 +1,143,649	+59%	+$30.3M	0.2%	141
2016 Q3	$61.9M	Buy	1,946,416 +103,599	+6%	+$3.51M	0.13%	180
2016 Q2	$59.8M	Sell	1,842,817 -206,730	-10%	-$6.92M	0.13%	183
2016 Q1	$57.3M	Buy	2,049,547 +278,294	+16%	+$6.07M	0.11%	187
2015 Q4	$63.1M	Sell	1,771,253 -333,651	-16%	-$11.8M	0.1%	187
2015 Q3	$69.6M	Sell	2,104,904 -147,652	-7%	-$6.14M	0.11%	185
2015 Q2	$94.3M	Sell	2,252,556 -383,915	-15%	-$14.9M	0.14%	176
2015 Q1	$85.9M	Buy	2,636,471 +285,722	+12%	+$9.82M	0.12%	188
2014 Q4	$74.6M	Buy	2,350,749 +324,625	+16%	+$9.21M	0.1%	190
2014 Q3	$50.2M	Buy	2,026,124 +492,628	+32%	+$11.5M	0.07%	225
2014 Q2	$34.6M	Buy	1,533,496 +655,786	+75%	+$13.7M	0.05%	282
2014 Q1	$21.4M	Buy	+877,710	New	+$22.2M	0.03%	333